its a targeted intervention for oxidative stress during rapid fat mobilisation
The common denominator between keto and GLP-1 agonists is blood sugar control[ii]
Paik D, Yao L, Zhang Y, Bae S, DAgostino GD, Zhang M, Kim E, Franzosa EA, Avila-Pacheco J, Bisanz JE, Rakowski CK, Vlamakis H, Xavier RJ, Turnbaugh PJ, Longman RS, Krout MR, Clish CB, Rastinejad F, Huttenhower C, Huh JR, Devlin AS (2022) Human gut bacteria produce TH17-modulating bile acid metabolites
These entrants are leveraging strengths in peptide synthesis, low-cost biologics manufacturing, and regulatory agility to shorten development cycles and undercut price points, potentially halving or even reducing cost to one-tenth of current therapy levels